Kiora Pharmaceuticals Total Risk Alpha
| KPRX Stock | | | USD 2.09 -0.06 -2.79% |
The Total Risk Alpha technical lookup provides context for Kiora Pharmaceuticals and related instruments. Availability can vary by instrument;
Equity Screeners offers additional screening access. Kiora Pharmaceuticals has a market cap of 7.69 M, ROE of -32.58%. Review
Correlation Analysis for broader portfolio context. This suggests a position in Kiora Pharmaceuticals across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in producer price index.
Our
How to Buy Kiora Stock guide explains the steps to invest in Kiora Pharmaceuticals stock.
Kiora Pharmaceuticals has current Total Risk Alpha of 0.1896. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.1896 | |
| ER[a] | = | Expected return on investing in Kiora Pharmaceuticals |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Kiora Pharmaceuticals |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Kiora Pharmaceuticals Total Risk Alpha Peers Comparison
Kiora Total Risk Alpha Relative To Other Indicators
Kiora Pharmaceuticals is rated
fifth in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
65.22 of Maximum Drawdown per Total Risk Alpha. At
65.22 , Kiora Pharmaceuticals's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.